首页 > 最新文献

Immunology & Cell Biology最新文献

英文 中文
ADAM10 modulates the efficacy of T-cell mediated therapy in solid tumors ADAM10调节实体瘤中t细胞介导治疗的疗效。
IF 3.2 4区 医学 Q3 CELL BIOLOGY Pub Date : 2025-01-20 DOI: 10.1111/imcb.12855
Ahmed ME Abdalla, Yu Miao, Ning Meng, Chenxi Ouyang

Immunology & Cell Biology 2025; 103: 213; https://doi.org/10.1111/imcb.12855

Correction to: Immunology & Cell Biology 2024; https://doi.10.1111/imcb.12826

The name of one of the authors is incorrect. Ning Ming should be Ning Meng. The correct spelling of this author's name appears in the title above.

{"title":"ADAM10 modulates the efficacy of T-cell mediated therapy in solid tumors","authors":"Ahmed ME Abdalla,&nbsp;Yu Miao,&nbsp;Ning Meng,&nbsp;Chenxi Ouyang","doi":"10.1111/imcb.12855","DOIUrl":"10.1111/imcb.12855","url":null,"abstract":"<p><i>Immunology &amp; Cell Biology</i> 2025; <b>103</b>: 213; https://doi.org/10.1111/imcb.12855</p><p>Correction to: <i>Immunology &amp; Cell Biology</i> 2024; https://doi.10.1111/imcb.12826</p><p>The name of one of the authors is incorrect. Ning Ming should be Ning Meng. The correct spelling of this author's name appears in the title above.</p>","PeriodicalId":179,"journal":{"name":"Immunology & Cell Biology","volume":"103 2","pages":"213"},"PeriodicalIF":3.2,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/imcb.12855","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142997009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An X-tra role for NFκB in gene regulation? NFκB在基因调控中的X-tra作用?
IF 3.2 4区 医学 Q3 CELL BIOLOGY Pub Date : 2025-01-10 DOI: 10.1111/imcb.12850
Sara Berent, Rhys S Allan

In this Research Highlight, we discuss recent research which shows that TCR-mediated activation and NF-κB signalling play an indispensable role in localising Xist RNA and its interactors to the inactive X chromosome (Xi) in T cells (left and middle). Inhibition of NF-κB disrupts this process, impairing the recruitment of silencing factors and jeopardizing the maintenance of X chromosome inactivation (right).

在本研究重点中,我们讨论了最近的研究,这些研究表明tcr介导的激活和NF-κB信号传导在T细胞中将Xist RNA及其相互作用物定位到失活的X染色体(Xi)中起着不可或缺的作用(左和中)。抑制NF-κB会破坏这一过程,损害沉默因子的募集,危及X染色体失活的维持(右)。
{"title":"An X-tra role for NFκB in gene regulation?","authors":"Sara Berent, Rhys S Allan","doi":"10.1111/imcb.12850","DOIUrl":"https://doi.org/10.1111/imcb.12850","url":null,"abstract":"<p><p>In this Research Highlight, we discuss recent research which shows that TCR-mediated activation and NF-κB signalling play an indispensable role in localising Xist RNA and its interactors to the inactive X chromosome (Xi) in T cells (left and middle). Inhibition of NF-κB disrupts this process, impairing the recruitment of silencing factors and jeopardizing the maintenance of X chromosome inactivation (right).</p>","PeriodicalId":179,"journal":{"name":"Immunology & Cell Biology","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142963473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Refining bone marrow ablation and reconstitution in mice. 改良小鼠骨髓消融和重建。
IF 3.2 4区 医学 Q3 CELL BIOLOGY Pub Date : 2025-01-09 DOI: 10.1111/imcb.12847
Penny Hawkins, James Dooley, Jessica Rodda, Colin Gilbert

This report presents findings from a group of UK-based researchers with expertise in the use of animal models for bone marrow ablation and reconstitution. The primary aim is to facilitate the implementation of the Three Rs (Replacement, Reduction and Refinement), with an emphasis on refinement. Bone marrow ablation and reconstitution procedures are performed for a number of different purposes and conducted predominantly in mice. These procedures can induce significant suffering, classified as "severe", Category E or Category D/E under European, US and Canadian legislation, respectively. Although severity categorization is not mandated in countries such as Australia and New Zealand, legislation still requires that the level of animal suffering must be minimized to the greatest extent possible. This report identifies specific animal welfare issues and proposes practical measures aimed at reducing both animal use and suffering.

本报告介绍了一组英国研究人员的研究结果,他们具有使用动物模型进行骨髓消融和重建的专业知识。主要目的是促进实施“三r”(替换、减少和改进),其中重点是改进。骨髓消融和重建手术有许多不同的目的,主要在小鼠中进行。根据欧洲、美国和加拿大的立法,这些手术可能会造成严重的痛苦,分别被归类为“严重”、E类或D/E类。虽然在澳大利亚和新西兰等国家没有强制规定严重程度分类,但立法仍然要求必须尽可能减少动物的痛苦程度。本报告确定了具体的动物福利问题,并提出了旨在减少动物使用和痛苦的实际措施。
{"title":"Refining bone marrow ablation and reconstitution in mice.","authors":"Penny Hawkins, James Dooley, Jessica Rodda, Colin Gilbert","doi":"10.1111/imcb.12847","DOIUrl":"https://doi.org/10.1111/imcb.12847","url":null,"abstract":"<p><p>This report presents findings from a group of UK-based researchers with expertise in the use of animal models for bone marrow ablation and reconstitution. The primary aim is to facilitate the implementation of the Three Rs (Replacement, Reduction and Refinement), with an emphasis on refinement. Bone marrow ablation and reconstitution procedures are performed for a number of different purposes and conducted predominantly in mice. These procedures can induce significant suffering, classified as \"severe\", Category E or Category D/E under European, US and Canadian legislation, respectively. Although severity categorization is not mandated in countries such as Australia and New Zealand, legislation still requires that the level of animal suffering must be minimized to the greatest extent possible. This report identifies specific animal welfare issues and proposes practical measures aimed at reducing both animal use and suffering.</p>","PeriodicalId":179,"journal":{"name":"Immunology & Cell Biology","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142941809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Learnings from ten years away from "home" as a South American immunologist in Ireland. 作为一名南美免疫学家,在爱尔兰远离“家乡”十年的学习。
IF 3.2 4区 医学 Q3 CELL BIOLOGY Pub Date : 2025-01-07 DOI: 10.1111/imcb.12849
Natalia Muñoz-Wolf

Pursuing an international scientific career is a fantastic opportunity for personal and professional growth, but it also poses unique challenges, which can be particularly daunting for researchers coming from resource-limited countries. Drawing from personal experience, this article provides insights into navigating the transition to working abroad in academia and developing a sustainable career while integrating into a new culture. From predeparture preparations to achieving career independence, I discuss practical aspects of crafting tailored applications to contact potential advisers, contemplating visa-related challenges, establishing collaborations and emphasizing the value of finding appropriate mentorship to help you adapt to new cultural and professional environments. The article also underscores the importance of resilience, adaptability and redefining career success as a dynamic, nonlinear process. I present an original perspective on career planning, inspired by maritime voyage planning, to address the complexities of balancing personal and professional life, particularly during transitional periods. This approach, which combines four key stages of planning, namely, appraisal, planning, execution and monitoring, serves as a model for early-career researchers to navigate the unpredictable tides of academic work and personal life abroad with the goal of sustaining progress and well-being. These reflections aim to empower scientists preparing for or adapting to international research environments, fostering resilience and adaptability for long-term success abroad.

追求国际科学事业是个人和专业成长的绝佳机会,但它也带来了独特的挑战,这对于来自资源有限国家的科学家来说可能特别令人生畏。根据个人经验,本文提供了如何在适应新文化的同时,顺利过渡到国外学术界工作,并发展可持续的职业生涯的见解。从出发前的准备到实现职业独立,我讨论了制作量身定制的申请的实际方面,以联系潜在的顾问,考虑签证相关的挑战,建立合作,并强调找到合适的导师的价值,以帮助你适应新的文化和专业环境。文章还强调了弹性、适应性以及将职业成功重新定义为一个动态、非线性过程的重要性。受航海规划的启发,我提出了一个关于职业规划的原创观点,以解决平衡个人生活和职业生活的复杂性,特别是在过渡时期。这种方法结合了计划的四个关键阶段,即评估、计划、执行和监测,为早期职业研究人员提供了一种模式,帮助他们在国外学术工作和个人生活的不可预测的浪潮中导航,目标是保持进步和幸福。这些反思的目的是使科学家能够为国际研究环境做准备或适应,培养在国外取得长期成功的韧性和适应性。
{"title":"Learnings from ten years away from \"home\" as a South American immunologist in Ireland.","authors":"Natalia Muñoz-Wolf","doi":"10.1111/imcb.12849","DOIUrl":"https://doi.org/10.1111/imcb.12849","url":null,"abstract":"<p><p>Pursuing an international scientific career is a fantastic opportunity for personal and professional growth, but it also poses unique challenges, which can be particularly daunting for researchers coming from resource-limited countries. Drawing from personal experience, this article provides insights into navigating the transition to working abroad in academia and developing a sustainable career while integrating into a new culture. From predeparture preparations to achieving career independence, I discuss practical aspects of crafting tailored applications to contact potential advisers, contemplating visa-related challenges, establishing collaborations and emphasizing the value of finding appropriate mentorship to help you adapt to new cultural and professional environments. The article also underscores the importance of resilience, adaptability and redefining career success as a dynamic, nonlinear process. I present an original perspective on career planning, inspired by maritime voyage planning, to address the complexities of balancing personal and professional life, particularly during transitional periods. This approach, which combines four key stages of planning, namely, appraisal, planning, execution and monitoring, serves as a model for early-career researchers to navigate the unpredictable tides of academic work and personal life abroad with the goal of sustaining progress and well-being. These reflections aim to empower scientists preparing for or adapting to international research environments, fostering resilience and adaptability for long-term success abroad.</p>","PeriodicalId":179,"journal":{"name":"Immunology & Cell Biology","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142941723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tumor-seeking bacterial missiles 寻找肿瘤的细菌导弹。
IF 3.2 4区 医学 Q3 CELL BIOLOGY Pub Date : 2025-01-05 DOI: 10.1111/imcb.12844
George Cavic, Aude M Fahrer
<p>In this exceptionally elegant and far-reaching study, the Arpaia lab at Columbia University engineer a probiotic <i>Escherichia coli</i> strain to eliminate cancer.<span><sup>1</sup></span></p><p>Working in two mouse models of cancer, CT26 colorectal cancer and B16F10 melanoma, Redenti <i>et al</i>.<span><sup>1</sup></span> start by identifying cancer-specific sequences. From these, they choose peptides containing (linked) MHCI and MHC II epitopes (about 25–30 amino acids long). They find that encoding a series of these in a plasmid, concatenated, but separated by five glycine-serine repeats, provides good expression of the neoantigens by <i>E. coli</i>.</p><p>They then turned to engineering EcN, a strain of <i>E. coli</i> isolated by Professor Alfred Nissle in 1917 from a young soldier resistant to infectious diarrhea.<span><sup>2</sup></span> Nissle marketed his discovery as a probiotic (Mutaflor®, still commercially available). Thus, Redenti <i>et al</i>. start with a safe, non-pathogenic <i>E. coli</i>, already extensively studied and widely used in humans (albeit orally).</p><p>Finding that their neoantigen plasmids express better in <i>E. coli</i> BL21 than in EcN, they set about modifying EcN to resemble BL21. Curing EcN of cryptic plasmids allows increased expression of the neoantigen-encoding plasmid. They then engineer deletions of two proteases: OmpT, which has roles in biofilm formation and the degradation of complement; and Lon which has pleiotropic roles within the bacterial cell, including oxygen-sensing.<span><sup>3</sup></span> Hence, deleting these proteases, not only reduced degradation of the neoantigen peptides, but also attenuates EcN. Although not discussed by the authors, deletion of the Lon protease may impede the survival of EcN in normal tissues more than in the anoxic core of the tumor, further reducing potential off-target effects. Overall, the authors show that their engineered EcN bacteria show an 80-fold increase in expression of the neoantigen peptides compared with the original EcN, and a 1000-fold increased susceptibility to phagocytosis and clearance from the blood.</p><p>In another stroke of genius, the authors next insert the gene for Listeriolysin O (LLO), a pore-forming protein which allows <i>Listeria</i> to escape into the cytosol after phagocytosis. This has two benefits: improved loading of neoantigen epitopes on MHC class I, and skewing towards a T<sub>H</sub>1 immune response after the sensing of intracytoplasmic bacteria.</p><p>The authors then turn to <i>in vivo</i> experiments to test their neoantigen-expressing, cryptic-plasmid cured, OmpT<sup>−</sup>, Lon<sup>−</sup>, LLO<sup>+</sup> EcN.</p><p>In both of the tumor models, EcN injected i.v. could consistently be cultured from tumors (3–4 days after injection), but could not be cultured from any of the other tissues tested, including the tumor-draining lymph node (TdLN). Despite this, i.v. injection of the EcN bacteria in the CT26 model was sho
{"title":"Tumor-seeking bacterial missiles","authors":"George Cavic,&nbsp;Aude M Fahrer","doi":"10.1111/imcb.12844","DOIUrl":"10.1111/imcb.12844","url":null,"abstract":"&lt;p&gt;In this exceptionally elegant and far-reaching study, the Arpaia lab at Columbia University engineer a probiotic &lt;i&gt;Escherichia coli&lt;/i&gt; strain to eliminate cancer.&lt;span&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;Working in two mouse models of cancer, CT26 colorectal cancer and B16F10 melanoma, Redenti &lt;i&gt;et al&lt;/i&gt;.&lt;span&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt; start by identifying cancer-specific sequences. From these, they choose peptides containing (linked) MHCI and MHC II epitopes (about 25–30 amino acids long). They find that encoding a series of these in a plasmid, concatenated, but separated by five glycine-serine repeats, provides good expression of the neoantigens by &lt;i&gt;E. coli&lt;/i&gt;.&lt;/p&gt;&lt;p&gt;They then turned to engineering EcN, a strain of &lt;i&gt;E. coli&lt;/i&gt; isolated by Professor Alfred Nissle in 1917 from a young soldier resistant to infectious diarrhea.&lt;span&gt;&lt;sup&gt;2&lt;/sup&gt;&lt;/span&gt; Nissle marketed his discovery as a probiotic (Mutaflor®, still commercially available). Thus, Redenti &lt;i&gt;et al&lt;/i&gt;. start with a safe, non-pathogenic &lt;i&gt;E. coli&lt;/i&gt;, already extensively studied and widely used in humans (albeit orally).&lt;/p&gt;&lt;p&gt;Finding that their neoantigen plasmids express better in &lt;i&gt;E. coli&lt;/i&gt; BL21 than in EcN, they set about modifying EcN to resemble BL21. Curing EcN of cryptic plasmids allows increased expression of the neoantigen-encoding plasmid. They then engineer deletions of two proteases: OmpT, which has roles in biofilm formation and the degradation of complement; and Lon which has pleiotropic roles within the bacterial cell, including oxygen-sensing.&lt;span&gt;&lt;sup&gt;3&lt;/sup&gt;&lt;/span&gt; Hence, deleting these proteases, not only reduced degradation of the neoantigen peptides, but also attenuates EcN. Although not discussed by the authors, deletion of the Lon protease may impede the survival of EcN in normal tissues more than in the anoxic core of the tumor, further reducing potential off-target effects. Overall, the authors show that their engineered EcN bacteria show an 80-fold increase in expression of the neoantigen peptides compared with the original EcN, and a 1000-fold increased susceptibility to phagocytosis and clearance from the blood.&lt;/p&gt;&lt;p&gt;In another stroke of genius, the authors next insert the gene for Listeriolysin O (LLO), a pore-forming protein which allows &lt;i&gt;Listeria&lt;/i&gt; to escape into the cytosol after phagocytosis. This has two benefits: improved loading of neoantigen epitopes on MHC class I, and skewing towards a T&lt;sub&gt;H&lt;/sub&gt;1 immune response after the sensing of intracytoplasmic bacteria.&lt;/p&gt;&lt;p&gt;The authors then turn to &lt;i&gt;in vivo&lt;/i&gt; experiments to test their neoantigen-expressing, cryptic-plasmid cured, OmpT&lt;sup&gt;−&lt;/sup&gt;, Lon&lt;sup&gt;−&lt;/sup&gt;, LLO&lt;sup&gt;+&lt;/sup&gt; EcN.&lt;/p&gt;&lt;p&gt;In both of the tumor models, EcN injected i.v. could consistently be cultured from tumors (3–4 days after injection), but could not be cultured from any of the other tissues tested, including the tumor-draining lymph node (TdLN). Despite this, i.v. injection of the EcN bacteria in the CT26 model was sho","PeriodicalId":179,"journal":{"name":"Immunology & Cell Biology","volume":"103 2","pages":"98-100"},"PeriodicalIF":3.2,"publicationDate":"2025-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/imcb.12844","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142929996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the dynamics of T-cell responses: a combined approach using EdU incorporation and proliferation dye dilution assay 探索t细胞反应的动力学:使用EdU掺入和增殖染料稀释试验的联合方法。
IF 3.2 4区 医学 Q3 CELL BIOLOGY Pub Date : 2024-12-30 DOI: 10.1111/imcb.12845
Hilde Raaphorst, Sinéad Lougheed, Latifa Saou, Nadine D van Kleef, Irma Rensink, Anja ten Brinke, Julian J Freen-van Heeren, Annelies W Turksma

Understanding antigen-specific T-cell responses is crucial for advancing immunotherapies and vaccine development. This study proposes a novel approach combining two complementary assays: the 5-ethynyl-2′-deoxyuridine (EdU) incorporation assay (tracking proliferation over 0–48 h) and the VPD450 dye dilution assay (tracking proliferation over 4–6 days). Integrating these techniques provides additional insights into T-cell proliferation kinetics. Both assays were independently optimized using anti-CD3 and anti-CD28 polyclonal T cell stimulation. 1 μM VPD450 is suitable for assessing T-cell proliferation. The EdU concentration should match the stimulation strength, requiring higher concentrations to efficiently track DNA replication detection during increased cellular division. Day 5 was the optimal read-out day for the EdU incorporation assay. We then combined the VPD450 dye dilution and EdU incorporation assays. As a proof of principle, we stimulated PBMCs from healthy donors with tetanus toxoid to assess antigen-specific T-cell responses. Additionally, we demonstrated the assay's application in drug research by evaluating proliferation in a mixed lymphocyte reaction with abatacept, an agonistic anti-CTLA-4 antibody. This combined approach offers qualitative insights into T-cell proliferation kinetics, beneficial for assessing novel vaccine efficiency or for designing new treatments targeting T cell proliferation, such as in autoimmune settings.

了解抗原特异性t细胞反应对于推进免疫疗法和疫苗开发至关重要。本研究提出了一种结合两种互补检测的新方法:5-乙基-2'-脱氧尿苷(EdU)掺入检测(追踪0-48小时的增殖)和VPD450染料稀释检测(追踪4-6天的增殖)。整合这些技术为t细胞增殖动力学提供了额外的见解。使用抗cd3和抗cd28多克隆T细胞刺激对两种检测方法进行独立优化。1 μM VPD450适用于评估t细胞增殖。EdU浓度应与刺激强度相匹配,需要更高的浓度才能在细胞分裂增加期间有效地跟踪DNA复制检测。第5天是EdU掺入试验的最佳读出日。然后结合VPD450染料稀释和EdU掺入试验。作为原理证明,我们用破伤风类毒素刺激来自健康供体的pbmc,以评估抗原特异性t细胞反应。此外,我们通过评估abatacept(一种激动性抗ctla -4抗体)在混合淋巴细胞反应中的增殖,证明了该方法在药物研究中的应用。这种结合的方法提供了对T细胞增殖动力学的定性见解,有利于评估新的疫苗效率或设计针对T细胞增殖的新治疗方法,例如在自身免疫环境中。
{"title":"Exploring the dynamics of T-cell responses: a combined approach using EdU incorporation and proliferation dye dilution assay","authors":"Hilde Raaphorst,&nbsp;Sinéad Lougheed,&nbsp;Latifa Saou,&nbsp;Nadine D van Kleef,&nbsp;Irma Rensink,&nbsp;Anja ten Brinke,&nbsp;Julian J Freen-van Heeren,&nbsp;Annelies W Turksma","doi":"10.1111/imcb.12845","DOIUrl":"10.1111/imcb.12845","url":null,"abstract":"<p>Understanding antigen-specific T-cell responses is crucial for advancing immunotherapies and vaccine development. This study proposes a novel approach combining two complementary assays: the 5-ethynyl-2′-deoxyuridine (EdU) incorporation assay (tracking proliferation over 0–48 h) and the VPD450 dye dilution assay (tracking proliferation over 4–6 days). Integrating these techniques provides additional insights into T-cell proliferation kinetics. Both assays were independently optimized using anti-CD3 and anti-CD28 polyclonal T cell stimulation. 1 μM VPD450 is suitable for assessing T-cell proliferation. The EdU concentration should match the stimulation strength, requiring higher concentrations to efficiently track DNA replication detection during increased cellular division. Day 5 was the optimal read-out day for the EdU incorporation assay. We then combined the VPD450 dye dilution and EdU incorporation assays. As a proof of principle, we stimulated PBMCs from healthy donors with tetanus toxoid to assess antigen-specific T-cell responses. Additionally, we demonstrated the assay's application in drug research by evaluating proliferation in a mixed lymphocyte reaction with abatacept, an agonistic anti-CTLA-4 antibody. This combined approach offers qualitative insights into T-cell proliferation kinetics, beneficial for assessing novel vaccine efficiency or for designing new treatments targeting T cell proliferation, such as in autoimmune settings.</p>","PeriodicalId":179,"journal":{"name":"Immunology & Cell Biology","volume":"103 2","pages":"178-191"},"PeriodicalIF":3.2,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142908691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chemokines in neurodegenerative diseases. 趋化因子在神经退行性疾病中的作用。
IF 3.2 4区 医学 Q3 CELL BIOLOGY Pub Date : 2024-12-26 DOI: 10.1111/imcb.12843
Hashemi Vida, Mehranfar Sahar, Amin Nikdouz, Hosseini Arezoo

Neurodegeneration and neuroinflammation disorders are mainly the result of the deposition of various proteins, such as α-synuclein, amyloid-β and prions, which lead to the initiation and activation of inflammatory responses. Different chemokines are involved in the infiltration and movement of inflammatory leukocytes into the central nervous system (CNS) that express chemokine receptors. Dysregulation of several members of chemokines has been shown in the CNS, cerebrospinal fluid and peripheral blood of patients who have neurodegenerative disorders. Upon infiltration of various cells, they produce many inflammatory mediators such as cytokines. Besides them, some CNS-resident cells, such as neurons and astrocytes, are also involved in the pathogenesis of neurodegeneration by producing chemokines. In this review, we summarize the role of chemokines and their related receptors in the pathogenesis of neurodegeneration and neuroinflammation disorders, including multiple sclerosis, Parkinson's disease and Alzheimer's disease. Therapeutic strategies targeting chemokines or their related receptors are also discussed in this article.

神经变性和神经炎症疾病主要是α-突触核蛋白、淀粉样蛋白-β和朊病毒等多种蛋白沉积导致炎症反应的启动和激活的结果。不同的趋化因子参与炎性白细胞向表达趋化因子受体的中枢神经系统(CNS)的浸润和运动。在患有神经退行性疾病的患者的中枢神经系统、脑脊液和外周血中已显示出几种趋化因子成员的失调。在浸润各种细胞后,它们产生许多炎症介质,如细胞因子。除此之外,一些中枢驻留细胞,如神经元和星形胶质细胞,也通过产生趋化因子参与神经变性的发病过程。本文就趋化因子及其相关受体在多发性硬化症、帕金森病和阿尔茨海默病等神经变性和神经炎症疾病发病机制中的作用进行综述。本文还讨论了针对趋化因子或其相关受体的治疗策略。
{"title":"Chemokines in neurodegenerative diseases.","authors":"Hashemi Vida, Mehranfar Sahar, Amin Nikdouz, Hosseini Arezoo","doi":"10.1111/imcb.12843","DOIUrl":"https://doi.org/10.1111/imcb.12843","url":null,"abstract":"<p><p>Neurodegeneration and neuroinflammation disorders are mainly the result of the deposition of various proteins, such as α-synuclein, amyloid-β and prions, which lead to the initiation and activation of inflammatory responses. Different chemokines are involved in the infiltration and movement of inflammatory leukocytes into the central nervous system (CNS) that express chemokine receptors. Dysregulation of several members of chemokines has been shown in the CNS, cerebrospinal fluid and peripheral blood of patients who have neurodegenerative disorders. Upon infiltration of various cells, they produce many inflammatory mediators such as cytokines. Besides them, some CNS-resident cells, such as neurons and astrocytes, are also involved in the pathogenesis of neurodegeneration by producing chemokines. In this review, we summarize the role of chemokines and their related receptors in the pathogenesis of neurodegeneration and neuroinflammation disorders, including multiple sclerosis, Parkinson's disease and Alzheimer's disease. Therapeutic strategies targeting chemokines or their related receptors are also discussed in this article.</p>","PeriodicalId":179,"journal":{"name":"Immunology & Cell Biology","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2024-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142890726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Innovations in Immunology Education: bridging theory, practice and professional development 免疫学教育的创新:衔接理论、实践和专业发展。
IF 3.2 4区 医学 Q3 CELL BIOLOGY Pub Date : 2024-12-23 DOI: 10.1111/imcb.12846
Samy Sakkal, Maurizio Costabile

{"title":"Innovations in Immunology Education: bridging theory, practice and professional development","authors":"Samy Sakkal,&nbsp;Maurizio Costabile","doi":"10.1111/imcb.12846","DOIUrl":"10.1111/imcb.12846","url":null,"abstract":"<p>\u0000 \u0000 <figure>\u0000 <div><picture>\u0000 <source></source></picture><p></p>\u0000 </div>\u0000 </figure>\u0000 </p>","PeriodicalId":179,"journal":{"name":"Immunology & Cell Biology","volume":"103 2","pages":"111-113"},"PeriodicalIF":3.2,"publicationDate":"2024-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/imcb.12846","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142875787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ILC1 as critical gatekeepers in autoimmune kidney damage ILC1是自身免疫性肾损伤的关键看门人。
IF 3.2 4区 医学 Q3 CELL BIOLOGY Pub Date : 2024-12-06 DOI: 10.1111/imcb.12842
Cyril Seillet, Le Xiong

A recent article has shown that blocking NKp46 signaling reduces injury, highlighting these cells as key drivers of organ damage and potential therapeutic targets in autoimmune diseases. In lupus nephritis, NKp46+ ILC1s orchestrate kidney inflammation by producing CSF2, driving the expansion of pro-inflammatory macrophages that infiltrate epithelial niches and exacerbate tissue damage.

最近的一篇文章表明,阻断NKp46信号可以减少损伤,强调这些细胞是自身免疫性疾病中器官损伤的关键驱动因素和潜在的治疗靶点。在狼疮性肾炎中,NKp46+ ILC1s通过产生CSF2来协调肾脏炎症,驱动促炎巨噬细胞的扩张,浸润上皮龛并加剧组织损伤。
{"title":"ILC1 as critical gatekeepers in autoimmune kidney damage","authors":"Cyril Seillet,&nbsp;Le Xiong","doi":"10.1111/imcb.12842","DOIUrl":"10.1111/imcb.12842","url":null,"abstract":"<p>A recent article has shown that blocking NKp46 signaling reduces injury, highlighting these cells as key drivers of organ damage and potential therapeutic targets in autoimmune diseases. In lupus nephritis, NKp46<sup>+</sup> ILC1s orchestrate kidney inflammation by producing CSF2, driving the expansion of pro-inflammatory macrophages that infiltrate epithelial niches and exacerbate tissue damage.\u0000 <figure>\u0000 <div><picture>\u0000 <source></source></picture><p></p>\u0000 </div>\u0000 </figure></p>","PeriodicalId":179,"journal":{"name":"Immunology & Cell Biology","volume":"103 1","pages":"9-11"},"PeriodicalIF":3.2,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/imcb.12842","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142790708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RNAi library screening reveals Gβ1, Casein Kinase 2 and ICAP-1 as novel regulators of LFA-1-mediated T cell polarity and migration RNAi 文库筛选发现 Gβ1、酪蛋白激酶 2 和 ICAP-1 是 LFA-1 介导的 T 细胞极性和迁移的新型调控因子。
IF 3.2 4区 医学 Q3 CELL BIOLOGY Pub Date : 2024-11-28 DOI: 10.1111/imcb.12838
Antje Haap-Hoff, Michael Freeley, Eugene Dempsey, Dara Dunican, Emily Bennett, Denise Triglia, Joanna Skubis-Zegadlo, Anthony Mitchell Davies, Dermot Kelleher, Aideen Long

The αLβ2 integrin LFA-1 plays a key role in T-cell adhesion to the endothelial vasculature and migration into both secondary lymphoid organs and peripheral tissues via interactions with its target protein ICAM-1, but the pathways that regulate LFA-1-mediated T-cell polarity and migration are not fully understood. In this study we screened two RNAi libraries targeting G protein-coupled receptors (GPCR)/GPCR-associated proteins and kinases in a HuT 78 T cell line model of LFA-1-stimulated T-cell migration. Based on staining of the actin cytoskeleton, multiple parameters to measure cell morphology were used to assess the contribution of 1109 genes to LFA-1-mediated T-cell polarity and migration. These RNAi screens identified a number of both novel and previously identified genes that either increased or decreased the polarity and migratory capacity of these cells. Following multiparametric analysis, hierarchical clustering and pathway analysis, three of these genes were characterized in further detail using primary human T cells, revealing novel roles for the heterotrimeric G protein subunit Gβ1 and Casein Kinase 2 in LFA-1-mediated T-cell polarity and migration in vitro. Our studies also highlighted a new role for ICAP-1, an adaptor protein previously described to be associated with β1 integrins, in β2 integrin LFA-1-directed migration in T cells. Knockdown of ICAP-1 expression in primary T cells revealed a role in cell polarity, cell velocity and transmigration towards SDF-1 for this adaptor protein. This study therefore uncovers new roles for GPCR/GPCR-associated proteins and kinases in T-cell migration and provides potential novel targets for modulation of the T-cell immune response.

αLβ2整合素LFA-1在T细胞粘附到内皮血管以及通过与其靶蛋白ICAM-1相互作用迁移到次级淋巴器官和外周组织的过程中起着关键作用,但调控LFA-1介导的T细胞极性和迁移的途径尚未完全清楚。在这项研究中,我们筛选了两个针对G蛋白偶联受体(GPCR)/GPCR相关蛋白和激酶的RNAi文库,在HuT 78 T细胞系模型中研究了LFA-1刺激的T细胞迁移。在肌动蛋白细胞骨架染色的基础上,使用多种参数测量细胞形态,以评估1109个基因对LFA-1介导的T细胞极性和迁移的贡献。这些 RNAi 筛选发现了一些新基因和以前发现的基因,它们增加或减少了这些细胞的极性和迁移能力。经过多参数分析、层次聚类和通路分析,我们利用原代人类 T 细胞对其中三个基因进行了进一步的详细鉴定,发现了异三聚 G 蛋白亚基 Gβ1 和酪蛋白激酶 2 在 LFA-1 介导的体外 T 细胞极性和迁移中的新作用。我们的研究还强调了ICAP-1在T细胞中β2整合素LFA-1定向迁移中的新作用,ICAP-1是一种适配蛋白,以前曾被描述为与β1整合素相关。通过敲除原代 T 细胞中 ICAP-1 的表达,发现了这种适配蛋白在细胞极性、细胞速度和向 SDF-1 迁移中的作用。因此,这项研究揭示了 GPCR/GPCR 相关蛋白和激酶在 T 细胞迁移中的新作用,并为调节 T 细胞免疫反应提供了潜在的新靶点。
{"title":"RNAi library screening reveals Gβ1, Casein Kinase 2 and ICAP-1 as novel regulators of LFA-1-mediated T cell polarity and migration","authors":"Antje Haap-Hoff,&nbsp;Michael Freeley,&nbsp;Eugene Dempsey,&nbsp;Dara Dunican,&nbsp;Emily Bennett,&nbsp;Denise Triglia,&nbsp;Joanna Skubis-Zegadlo,&nbsp;Anthony Mitchell Davies,&nbsp;Dermot Kelleher,&nbsp;Aideen Long","doi":"10.1111/imcb.12838","DOIUrl":"10.1111/imcb.12838","url":null,"abstract":"<p>The α<sub>L</sub>β<sub>2</sub> integrin LFA-1 plays a key role in T-cell adhesion to the endothelial vasculature and migration into both secondary lymphoid organs and peripheral tissues via interactions with its target protein ICAM-1, but the pathways that regulate LFA-1-mediated T-cell polarity and migration are not fully understood. In this study we screened two RNAi libraries targeting G protein-coupled receptors (GPCR)/GPCR-associated proteins and kinases in a HuT 78 T cell line model of LFA-1-stimulated T-cell migration. Based on staining of the actin cytoskeleton, multiple parameters to measure cell morphology were used to assess the contribution of 1109 genes to LFA-1-mediated T-cell polarity and migration. These RNAi screens identified a number of both novel and previously identified genes that either increased or decreased the polarity and migratory capacity of these cells. Following multiparametric analysis, hierarchical clustering and pathway analysis, three of these genes were characterized in further detail using primary human T cells, revealing novel roles for the heterotrimeric G protein subunit Gβ1 and Casein Kinase 2 in LFA-1-mediated T-cell polarity and migration <i>in vitro</i>. Our studies also highlighted a new role for ICAP-1, an adaptor protein previously described to be associated with β1 integrins, in β2 integrin LFA-1-directed migration in T cells. Knockdown of ICAP-1 expression in primary T cells revealed a role in cell polarity, cell velocity and transmigration towards SDF-1 for this adaptor protein. This study therefore uncovers new roles for GPCR/GPCR-associated proteins and kinases in T-cell migration and provides potential novel targets for modulation of the T-cell immune response.</p>","PeriodicalId":179,"journal":{"name":"Immunology & Cell Biology","volume":"103 1","pages":"73-92"},"PeriodicalIF":3.2,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11688611/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142737913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Immunology & Cell Biology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1